These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 19838194)

  • 61. Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
    Rasekh EO; Atef AM; Khalil M; Ebeid E; Madney Y; Hamdy N
    Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491417
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in
    Sia KCS; Zhong L; Mayoh C; Norris MD; Haber M; Marshall GM; Raftery MJ; Lock RB
    Mol Cancer Res; 2020 Dec; 18(12):1767-1776. PubMed ID: 32801162
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.
    Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ
    Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.
    Desikan SP; Senapati J; Jabbour E; Abuasab T; Short N; Tang G; Wang S; Kebriaei P; Kadia T; Borthakur G; Ravandi F; Roberts K; Mullighan C; Konopleva M; Kantarjian H; Jain N
    Am J Hematol; 2023 Jun; 98(6):E142-E144. PubMed ID: 36877196
    [No Abstract]   [Full Text] [Related]  

  • 65. JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias.
    Kim SK; Knight DA; Jones LR; Vervoort S; Ng AP; Seymour JF; Bradner JE; Waibel M; Kats L; Johnstone RW
    Genes Dev; 2018 Jun; 32(11-12):849-864. PubMed ID: 29907650
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The acute lymphoblastic leukemia of Down Syndrome - Genetics and pathogenesis.
    Izraeli S
    Eur J Med Genet; 2016 Mar; 59(3):158-61. PubMed ID: 26631987
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.
    Gaikwad A; Rye CL; Devidas M; Heerema NA; Carroll AJ; Izraeli S; Plon SE; Basso G; Pession A; Rabin KR
    Br J Haematol; 2009 Mar; 144(6):930-2. PubMed ID: 19120350
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.
    Loh ML; Zhang J; Harvey RC; Roberts K; Payne-Turner D; Kang H; Wu G; Chen X; Becksfort J; Edmonson M; Buetow KH; Carroll WL; Chen IM; Wood B; Borowitz MJ; Devidas M; Gerhard DS; Bowman P; Larsen E; Winick N; Raetz E; Smith M; Downing JR; Willman CL; Mullighan CG; Hunger SP
    Blood; 2013 Jan; 121(3):485-8. PubMed ID: 23212523
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of High-risk Cryptic CRLF2 Rearrangements in B-Cell Acute Lymphoblastic Leukemia Utilizing an FGFR3/IGH Dual-Color Dual-Fusion DNA Probe Set.
    Robin AJ; Peterson JF; Grignon JW; Gheorghe G; Burke MJ; vanTuinen P
    J Pediatr Hematol Oncol; 2017 May; 39(4):e207-e210. PubMed ID: 27820126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
    Chang Y; Min J; Jarusiewicz JA; Actis M; Yu-Chen Bradford S; Mayasundari A; Yang L; Chepyala D; Alcock LJ; Roberts KG; Nithianantham S; Maxwell D; Rowland L; Larsen R; Seth A; Goto H; Imamura T; Akahane K; Hansen BS; Pruett-Miller SM; Paietta EM; Litzow MR; Qu C; Yang JJ; Fischer M; Rankovic Z; Mullighan CG
    Blood; 2021 Dec; 138(23):2313-2326. PubMed ID: 34110416
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Philadelphia Chromosome-like Mixed-Phenotype Acute Leukemia Demonstrating P2RY8-CRLF2 Fusion and JAK1 Mutation.
    Choi SM; Frederiksen JK; Ross CW; Bixby DL; Shao L
    Am J Clin Pathol; 2017 Nov; 148(6):523-528. PubMed ID: 29140408
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia.
    Mittelman SD; Kim J; Raca G; Li G; Oberley MJ; Orgel E
    Blood; 2021 Jul; 138(2):199-202. PubMed ID: 33876219
    [No Abstract]   [Full Text] [Related]  

  • 73. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
    Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
    Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
    Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
    J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
    Jain N; Roberts KG; Jabbour E; Patel K; Eterovic AK; Chen K; Zweidler-McKay P; Lu X; Fawcett G; Wang SA; Konoplev S; Harvey RC; Chen IM; Payne-Turner D; Valentine M; Thomas D; Garcia-Manero G; Ravandi F; Cortes J; Kornblau S; O'Brien S; Pierce S; Jorgensen J; Shaw KR; Willman CL; Mullighan CG; Kantarjian H; Konopleva M
    Blood; 2017 Feb; 129(5):572-581. PubMed ID: 27919910
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Characteristics and Clinical Significance of CRLF2 Mutations in Adult Acute Lymphoblastic Leukemia].
    Gu Y; Wu YJ; Han Q; Zhou XL; Qiao C; Li JY; Ge Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):328-333. PubMed ID: 28446270
    [TBL] [Abstract][Full Text] [Related]  

  • 77. JAK2--a new player in acute lymphoblastic leukaemia.
    Mullighan CG
    Lancet; 2008 Oct; 372(9648):1448-50. PubMed ID: 18805580
    [No Abstract]   [Full Text] [Related]  

  • 78. Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.
    Yano M; Imamura T; Asai D; Kiyokawa N; Nakabayashi K; Matsumoto K; Deguchi T; Hashii Y; Honda YK; Hasegawa D; Sasahara Y; Ishii M; Kosaka Y; Kato K; Shima M; Hori H; Yumura-Yagi K; Hara J; Oda M; Horibe K; Ichikawa H; Sato A
    Br J Haematol; 2015 Dec; 171(5):813-7. PubMed ID: 26404892
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL.
    Sasaki K; Yamauchi T; Semba Y; Nogami J; Imanaga H; Terasaki T; Nakao F; Akahane K; Inukai T; Verhoeyen E; Akashi K; Maeda T
    Blood; 2022 Feb; 139(5):748-760. PubMed ID: 34587248
    [TBL] [Abstract][Full Text] [Related]  

  • 80. How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.
    Roberts KG; Mullighan CG
    Curr Opin Pediatr; 2011 Feb; 23(1):34-40. PubMed ID: 21169835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.